Adetokunboh O, Awotiwon A, Ndwandwe D, Uthman O, Wiysonge C
Hum Vaccin Immunother. 2019; 15(11):2590-2605.
PMID: 30945963
PMC: 6930054.
DOI: 10.1080/21645515.2019.1599676.
Jain S, Seth A, Khare S, Chandra J
Indian J Med Res. 2017; 145(4):536-542.
PMID: 28862187
PMC: 5663169.
DOI: 10.4103/ijmr.IJMR_44_16.
Rabie H, Goussard P
Pneumonia (Nathan). 2017; 8:19.
PMID: 28702298
PMC: 5471701.
DOI: 10.1186/s41479-016-0021-y.
Njoroge S, Matumba L, Kanenga K, Siambi M, Waliyar F, Maruwo J
Mycotoxin Res. 2017; 33(2):113-119.
PMID: 28124218
DOI: 10.1007/s12550-017-0270-5.
Lin W, Nelson A, Ryon J, Moss W, Griffin D
J Infect Dis. 2017; 215(5):830-839.
PMID: 28119485
PMC: 5388292.
DOI: 10.1093/infdis/jix012.
Spatial clustering of measles cases during endemic (1998-2002) and epidemic (2010) periods in Lusaka, Zambia.
Pinchoff J, Chipeta J, Banda G, Miti S, Shields T, Curriero F
BMC Infect Dis. 2015; 15:121.
PMID: 25888228
PMC: 4377180.
DOI: 10.1186/s12879-015-0842-y.
Measles resurgence in southern Africa: challenges to measles elimination.
Shibeshi M, Masresha B, Smit S, Biellik R, Nicholson J, Muitherero C
Vaccine. 2014; 32(16):1798-807.
PMID: 24530936
PMC: 10292670.
DOI: 10.1016/j.vaccine.2014.01.089.
Severe Measles Infection: The Spectrum of Disease in 36 Critically Ill Adult Patients.
Rafat C, Klouche K, Ricard J, Messika J, Roch A, Machado S
Medicine (Baltimore). 2013; 92(5):257-272.
PMID: 23982057
PMC: 4553975.
DOI: 10.1097/MD.0b013e3182a713c2.
Vaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a DNA vaccine encoding the measles virus hemagglutinin and fusion proteins.
Lin W, Vilalta A, Adams R, Rolland A, Sullivan S, Griffin D
J Virol. 2013; 87(12):6560-8.
PMID: 23552419
PMC: 3676108.
DOI: 10.1128/JVI.00635-13.
Measles virus, immune control, and persistence.
Griffin D, Lin W, Pan C
FEMS Microbiol Rev. 2012; 36(3):649-62.
PMID: 22316382
PMC: 3319515.
DOI: 10.1111/j.1574-6976.2012.00330.x.
Assessment of the epidemiology and burden of measles in Southern Mozambique.
Mandomando I, Naniche D, Pasetti M, Cuberos L, Sanz S, Valles X
Am J Trop Med Hyg. 2011; 85(1):146-51.
PMID: 21734140
PMC: 3122359.
DOI: 10.4269/ajtmh.2011.10-0517.
Biological feasibility of measles eradication.
Moss W, Strebel P
J Infect Dis. 2011; 204 Suppl 1:S47-53.
PMID: 21666201
PMC: 3112320.
DOI: 10.1093/infdis/jir065.
Measles virus-induced immunosuppression: from effectors to mechanisms.
Avota E, Gassert E, Schneider-Schaulies S
Med Microbiol Immunol. 2010; 199(3):227-37.
PMID: 20376484
DOI: 10.1007/s00430-010-0152-3.
Emergence and re-emergence of viral diseases of the central nervous system.
Griffin D
Prog Neurobiol. 2009; 91(2):95-101.
PMID: 20004230
PMC: 2860042.
DOI: 10.1016/j.pneurobio.2009.12.003.
HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection.
Nair N, Moss W, Scott S, Mugala N, Ndhlovu Z, Lilo K
J Infect Dis. 2009; 200(7):1031-8.
PMID: 19702505
PMC: 2938771.
DOI: 10.1086/605648.
Measles control and the prospect of eradication.
Moss W
Curr Top Microbiol Immunol. 2009; 330:173-89.
PMID: 19203110
PMC: 7120973.
DOI: 10.1007/978-3-540-70617-5_9.
Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus.
Pan C, Jimenez G, Nair N, Wei Q, Adams R, Polack F
Clin Vaccine Immunol. 2008; 15(8):1214-21.
PMID: 18524884
PMC: 2519314.
DOI: 10.1128/CVI.00120-08.
Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.
Pan C, Nair N, Adams R, Zink M, Lee E, Polack F
Clin Vaccine Immunol. 2008; 15(4):697-706.
PMID: 18287579
PMC: 2292652.
DOI: 10.1128/CVI.00045-08.
Gene expression changes in peripheral blood mononuclear cells during measles virus infection.
Zilliox M, Moss W, Griffin D
Clin Vaccine Immunol. 2007; 14(7):918-23.
PMID: 17538120
PMC: 1951064.
DOI: 10.1128/CVI.00031-07.
Measles in the United Kingdom: can we eradicate it by 2010?.
Asaria P, MacMahon E
BMJ. 2006; 333(7574):890-5.
PMID: 17068034
PMC: 1626346.
DOI: 10.1136/bmj.38989.445845.7C.